We have been castigating the FDA for blocking an effective stem cell therapy for heart disease. As reported in the Houston Chronicle, the FDA has relented. Recent studies have raised questions about this type of therapy, but it seems that there are several similar types of therapy under discussion. From the article: "All of the 14 Brazilian patients showed some sign of improvement in their heart function after receiving stem cell injections, researchers said, including the ability of the heart muscle to pump blood. Several have even begun jogging. Although it is a very small sample of patients, just two have died in the nearly two years of monitoring, when, without treatment, half or more might have died."